Effect of 12-week Intermittent Calorie Restriction Compared to Standard of Care in Patients with Nonalcoholic Fatty Liver Disease: a Randomized Controlled Trial

Overview

Journal Trials

Publisher Biomed Central

Specialties General Medicine
Pharmacology

Date 2023 Aug 2

PMID 37533096

Authors

Han Ah Lee

Hyeyoung Moon

Yuri Kim

Hye Ah Lee

Hwi Young Kim

Affiliations

Soon will be listed here.

Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. NAFLD can result in various complications. Owing to the lack of effective pharmacological therapies, lifestyle modifications are the cornerstone treatment for NAFLD. However, there has been no recommendation for a specific dietary therapy. Because no significant effects have been observed in previous studies. Intermittent calorie restriction (ICR) consists of alternating phases of extreme energy restriction and regular energy intake. Recent studies have demonstrated a significantly higher reduction in liver fat content in the ICR group than in the standard of care (SOC) or continuous calorie restriction groups in patients with NAFLD. However, critical weaknesses limit the broader application of ICR in clinical practice; those are a lack of appropriate assessment tools, different cutoffs of body mass index (BMI) used to define obesity, and different food portions. Thus, we report a protocol for a prospective, randomized controlled trial. The trial will evaluate the effect of 12-week ICR on improving liver fat content in NAFLD patients (Nonalcoholic Fatty Liver Disease-Intermittent Calorie Restriction [FLICR]).

Methods: We will include adult (19-75 years) NAFLD patients. NAFLD will be diagnosed by histologic assessment or magnetic resonance imaging-proton density fat fraction (MRI-PDFF) ≥ 8%. A total of 72 patients will be classified according to BMI (obese group: BMI ≥ 25 kg/m [n = 36] and non-obese group: BMI < 25 kg/m [n = 36]). Participants will be followed up for 24 weeks. Participants will be randomly assigned to one of the two groups: the SOC or ICR group. The primary objective will be the change in liver fat content measured using MRI-PDFF from baseline to 12 weeks.

Discussion: This FLICR study may provide clinical evidence on ICR in the treatment of NAFLD in both obese and non-obese patients. The use of ICR in patients with NAFLD will improve the clinical outcomes of patients facing a shortage of effective medical therapy.

Trial Registration: This trial was registered at the United States National Library of Medicine (NLM) at the National Institutes of Health.

Clinicaltrials: gov NCT05309642. Registered on April 4, 2022.

Citing Articles

Effect of Intermittent vs. Continuous Energy Restriction on Visceral Fat: Protocol for The Healthy Diet and Lifestyle Study 2 (HDLS2).

Lewis M, Yonemori K, Ross A, Wilkens L, Shepherd J, Cassel K Nutrients. 2024; 16(10).

PMID: 38794715 PMC: 11123735. DOI: 10.3390/nu16101478.

References

Seo M, Lee W, Kim S, Kang J, Kang J, Kim K . 2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea. J Obes Metab Syndr. 2019; 28(1):40-45. PMC: 6484940. DOI: 10.7570/jomes.2019.28.1.40. View

Younossi Z, Tacke F, Arrese M, Sharma B, Mostafa I, Bugianesi E . Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology. 2018; 69(6):2672-2682. DOI: 10.1002/hep.30251. View

Schubel R, Nattenmuller J, Sookthai D, Nonnenmacher T, Graf M, Riedl L . Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk: a randomized controlled trial. Am J Clin Nutr. 2018; 108(5):933-945. PMC: 6915821. DOI: 10.1093/ajcn/nqy196. View

Wong V, Wong G, Chan R, Shu S, Cheung B, Li L . Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. J Hepatol. 2018; 69(6):1349-1356. DOI: 10.1016/j.jhep.2018.08.011. View

Chalasani N, Younossi Z, Lavine J, Charlton M, Cusi K, Rinella M . The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2017; 67(1):328-357. DOI: 10.1002/hep.29367. View

Brunt E, Kleiner D, Carpenter D, Rinella M, Harrison S, Loomba R . NAFLD: Reporting Histologic Findings in Clinical Practice. Hepatology. 2020; 73(5):2028-2038. DOI: 10.1002/hep.31599. View

Davison B, Harrison S, Cotter G, Alkhouri N, Sanyal A, Edwards C . Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. J Hepatol. 2020; 73(6):1322-1332. DOI: 10.1016/j.jhep.2020.06.025. View

Johari M, Yusoff K, Haron J, Nadarajan C, Ibrahim K, Wong M . A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease. Sci Rep. 2019; 9(1):11232. PMC: 6677794. DOI: 10.1038/s41598-019-47763-8. View

Younossi Z, Corey K, Lim J . AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology. 2020; 160(3):912-918. DOI: 10.1053/j.gastro.2020.11.051. View

10.

Rinella M, Neuschwander-Tetri B, Siddiqui M, Abdelmalek M, Caldwell S, Barb D . AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023; 77(5):1797-1835. PMC: 10735173. DOI: 10.1097/HEP.0000000000000323. View

11.

Harvie M, Pegington M, Mattson M, Frystyk J, Dillon B, Evans G . The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond). 2010; 35(5):714-27. PMC: 3017674. DOI: 10.1038/ijo.2010.171. View

12.

Kirk E, Reeds D, Finck B, Mayurranjan S, Mayurranjan M, Patterson B . Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology. 2009; 136(5):1552-60. PMC: 2677125. DOI: 10.1053/j.gastro.2009.01.048. View

13.

Ahn J, Won Jun D, Lee H, Moon J . Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses. Clin Nutr. 2018; 38(5):2023-2030. DOI: 10.1016/j.clnu.2018.09.022. View

14.

Kim H . Recent advances in nonalcoholic fatty liver disease metabolomics. Clin Mol Hepatol. 2021; 27(4):553-559. PMC: 8524071. DOI: 10.3350/cmh.2021.0127. View

15.

Harvie M, Wright C, Pegington M, McMullan D, Mitchell E, Martin B . The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr. 2013; 110(8):1534-47. PMC: 5857384. DOI: 10.1017/S0007114513000792. View

16.

Rozanski G, Pheby D, Newton J, Murovska M, Zalewski P, Slomko J . Effect of Different Types of Intermittent Fasting on Biochemical and Anthropometric Parameters among Patients with Metabolic-Associated Fatty Liver Disease (MAFLD)-A Systematic Review. Nutrients. 2022; 14(1). PMC: 8747070. DOI: 10.3390/nu14010091. View

17.

Kang S, Lee H, Yoo J, Cho Y, Kim S, Lee T . KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2021; 27(3):363-401. PMC: 8273632. DOI: 10.3350/cmh.2021.0178. View

18.

Sundfor T, Svendsen M, Tonstad S . Intermittent calorie restriction-a more effective approach to weight loss?. Am J Clin Nutr. 2018; 108(5):909-910. DOI: 10.1093/ajcn/nqy288. View

19.

Retterstol K, Svendsen M, Narverud I, Holven K . Effect of low carbohydrate high fat diet on LDL cholesterol and gene expression in normal-weight, young adults: A randomized controlled study. Atherosclerosis. 2018; 279:52-61. DOI: 10.1016/j.atherosclerosis.2018.10.013. View

20.

Adams L, Lymp J, Sauver J, Sanderson S, Lindor K, Feldstein A . The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005; 129(1):113-21. DOI: 10.1053/j.gastro.2005.04.014. View